StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Stryker by Quarter

Stryker — U.S. FDA Premarket Approvals (PMA & Supplements, approvals)

QuarterlyAnnualMonthly

Stryker Stryker: 2 in Q3 2026, unchanged from a year earlier.

Latest, Q3 2026
2
Period ended Sep 30, 2026
Change on a year earlier
0.0%
2 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker

Where the Q3 2026 figure comes from

Source: U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStryker — U.S. FDA Premarket Approvals (PMA & Supplements, approvals)Year on yearSource
Q3 2026Sep 30, 202620.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2026Jun 30, 20261-66.7%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2026Mar 31, 202610.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2025Dec 31, 20251-75.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2025Sep 30, 20252-71.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2025Jun 30, 202530.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2025Mar 31, 202510.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2024Dec 31, 20244+100.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2024Sep 30, 20247+133.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2024Jun 30, 20243+200.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2024Mar 31, 202410.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2023Dec 31, 20232+100.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2023Sep 30, 20233+50.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2023Jun 30, 20231–U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2023Mar 31, 20231-66.7%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2022Dec 31, 20221-50.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Cite this data

StockData. (2026). Stryker Stryker, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ext-fda-pma

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.